马来酸乙巯拉嗪
中文名称 | 马来酸乙巯拉嗪 |
---|---|
中文同义词 | 马来酸乙巯拉嗪;马来酸乙巯拉嗪 USP标准品;二马来酸硫乙基哌嗪;化合物 T17072 |
英文名称 | THIETHYLPERAZINE MALEATE (200 MG) |
英文同义词 | gs-95;nsc-130044;thiethylperazinedimaleate;thiethylperazinemaleate;torecan;torecanbimaleate;torecandimaleate;torecanmaleate |
CAS号 | 1179-69-7 |
分子式 | C4H2O4-2 |
分子量 | 114.05628 |
EINECS号 | 2146489 |
相关类别 | |
Mol文件 | 1179-69-7.mol |
结构式 |
马来酸乙巯拉嗪 性质
熔点 | >146oC (dec.) |
---|---|
储存条件 | Hygroscopic, -20°C Freezer, Under inert atmosphere |
溶解度 | 可溶于DMSO(轻微)、甲醇(轻微、加热) |
形态 | 固体 |
颜色 | 灰白色至浅黄色 |
稳定性 | 吸湿性 |
Dopamine D2-receptor
Histamine H1-receptor
ABCC1
Enterococcus faecalis
Thiethylperazine could enhance the antibiotic (Vancomycin) activity at a concentration as low as 2 μg/mL. Thiethylperazine inhibits Vancomycin-sensitive E. faecalis ATCC 29212, Vancomycin-resistant E. faecalis ATCC 51299 and vancomycin-resistant E. faecalis (VREF) isolates with MIC values of 8 μg/mL, 16 μg/mL and 8 μg/mL, respectively.
Thiethylperazine (3 mg/kg; intramuscular injection; twice daily; for 30 days; young APP/PS1 mice) treatment significantly reduces Aβ42 levels in APP/PS1 mice.
Animal Model: | Young Aβ precursor protein (APPswe) and mutant presenilin-1 (PS1) ( APP/PS1 ) mice |
Dosage: | 3 mg/kg |
Administration: | Intramuscular injection; twice daily; for 30 days |
Result: | Significantly reduced Aβ42 levels in APP/PS1 mice. |
安全信息
海关编码 | 2934302700 |
---|